BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11922613)

  • 1. Intestinal metabolism and absorption of cholecystokinin analogs in rats.
    Su SF; Amidon GL; Lee HJ
    Biochem Biophys Res Commun; 2002 Apr; 292(3):632-8. PubMed ID: 11922613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible degradative process of cholecystokinin analogs in rabbit jejunum brush-border membrane vesicles.
    Su SF; Amidon GL; Lee HJ
    Life Sci; 2002 Nov; 72(1):35-47. PubMed ID: 12409143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of enzyme inhibitor and absorption site following [D-ala2, D-leu5]enkephalin oral administration in rats.
    Lee HJ; Amidon GL
    Biopharm Drug Dispos; 2002 May; 23(4):131-41. PubMed ID: 12015787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine absorption and elimination in rat small intestine.
    Piyapolrungroj N; Zhou YS; Li C; Liu G; Zimmermann E; Fleisher D
    Drug Metab Dispos; 2000 Jan; 28(1):65-72. PubMed ID: 10611142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation into the intestinal metabolism of [D-Ala1] peptide T amide: implication for oral drug delivery.
    Su SF; Amidon GL
    Biochim Biophys Acta; 1995 Aug; 1245(1):62-8. PubMed ID: 7654767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral absorption of peptides: influence of pH and inhibitors on the intestinal hydrolysis of leu-enkephalin and analogues.
    Friedman DI; Amidon GL
    Pharm Res; 1991 Jan; 8(1):93-6. PubMed ID: 2014216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of brush-border membrane peptidases along the intestine of rabbits and rats: implication for site-specific delivery of peptide drugs.
    Bai JP
    J Drug Target; 1993; 1(3):231-6. PubMed ID: 8069564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate drug delivery routes for A-71623, a potent cholecystokinin-A receptor agonist tetrapeptide.
    Cannon JB; Adjei LA; Lu MY; Garren K
    J Drug Target; 1996; 4(2):69-78. PubMed ID: 8894966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of intestinal absorption and exsorption of digoxin in rats.
    Yao HM; Chiou WL
    Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption of rivastigmine from different regions of the gastrointestinal tract in humans.
    Lee L; Hossain M; Wang Y; Sedek G
    J Clin Pharmacol; 2004 Jun; 44(6):599-604. PubMed ID: 15145967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus.
    Shimomura M; Masuda S; Saito H; Sakamoto S; Uemoto S; Tanaka K; Inui K
    J Surg Res; 2002 Apr; 103(2):215-22. PubMed ID: 11922737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans.
    Li C; Liu T; Broske L; Brisson JM; Uss AS; Njoroge FG; Morrison RA; Cheng KC
    Biochem Pharmacol; 2008 Dec; 76(12):1757-64. PubMed ID: 18835257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral absorption of peptides: the effect of absorption site and enzyme inhibition on the systemic availability of metkephamid.
    Langguth P; Merkle HP; Amidon GL
    Pharm Res; 1994 Apr; 11(4):528-35. PubMed ID: 8058610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiolabeling approaches for cholecystokinin B receptor imaging.
    Aloj L; Panico MR; Caracó C; Zannetti A; Del Vecchio S; Di Nuzzo C; Arra C; Morelli G; Tesauro D; De Luca S; Pedone C; Salvatore M
    Biopolymers; 2002; 66(6):370-80. PubMed ID: 12658724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding specificity of the mouse cerebral cortex receptor for small cholecystokinin peptides.
    Steigerwalt RW; Williams JA
    Regul Pept; 1984 Jan; 8(1):51-9. PubMed ID: 6326203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced permeability of tetragastrin across the rat intestinal membrane and its reduced degradation by acylation with various fatty acids.
    Yodoya E; Uemura K; Tenma T; Fujita T; Murakami M; Yamamoto A; Muranishi S
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1509-13. PubMed ID: 7996464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.